COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 162: Articles 1611-1620  | Next

An institutional COVID-19 initiative: creation of a biobank and serological data analysis in pre- and post-vaccination cohorts
Fernandes-Siqueira, L. O., Melo, R. R. A., Wermelinger, L. S., Almeida, F. C. L., Salmon, D., Ferreira, G. C., Da Poian, A. T.
10.1101/2024.11.05.24316633 — Posted: 2024-11-05
Direct lipid interactions control SARS-CoV-2 M protein conformational dynamics and virus assembly
Dutta, M., Dolan, K. A., Amiar, S., Bass, E. J., Sultana, R., Voth, G. A., Stahelin, R. V., Brohawn, S. G.
10.1101/2024.11.04.620124 — Posted: 2024-11-05
Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives KP.3, KP.3.1.1, LB.1, and XEC
Sano, K., Miyakawa, K., Kato, H., Kimura, Y., Goto, A., Ryo, A., Watanabe, S., Hasegawa, H.
10.1101/2024.11.04.621772 — Posted: 2024-11-05
Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein
Cuypers, M.-L., Jaspers, T., Clerckx, J., Leekens, S., Cawthorne, C., Bormans, G., Cleeren, F., Geukens, N., De Strooper, B., Dewilde, M.
10.1101/2024.11.04.621218 — Posted: 2024-11-05
Sex differences in ACE2, TMPRSS2, and HLA-DQA2 expression in gray matter: Implications for post-COVID-19 neurological symptoms
Kesler, S. R., Schutz, A. D., Franco-Rocha, O. Y., Lewis, K.
10.1101/2024.11.04.24316706 — Posted: 2024-11-04
The Maximal Expected Benefit of SARS-CoV-2 Interventions Among University Students: A Simulation Study Using Latent Class Analysis
Arnold, C. R., Bharti, N., Exten, C., Small, M., Srinivasan, S. V., Kuchipudi, S., Kapur, V., Ferrari, M.
10.1101/2024.11.04.24316707 — Posted: 2024-11-04
The Basel Long COVID Cohort Study (BALCoS): protocol of a prospective cohort study
Rohner, S., Schnepper, R., Meinlschmidt, G., Schaefert, R., Mayr, M., Bopp, K., Meienberg, A.
10.1101/2024.10.29.24316282 — Posted: 2024-11-04
Emerging pathogens associated with acute respiratory infections in children before, during and after the COVID-19 pandemic in Hanoi, Vietnam
Ho, N. T., Nguyen, H. T. T., Hoang, H. T., Pham, D. V., Nguyen, Q. N., Le, H. T. M., Pham, A. N., Doan, P. M.
10.1101/2024.11.02.24316627 — Posted: 2024-11-04
The burden of SARS-CoV-2 Infection and Severe Illness in South Africa March 2020-August 2022: A synthesis of epidemiological data
Bolton, L., Tempia, S., Walaza, S., Jassat, W., Sun, K., Bradshaw, D., Dorrington, R., Kleynhans, J., Martinson, N., von Gottberg, A., Wolter, N., Pulliam, J. R. C., Cohen, C.
10.1101/2024.10.30.24316404 — Posted: 2024-11-04
An Assessment of the Effects of Coronavirus Disease 2019 (COVID-19) on Community Pharmacy Service Delivery in Lagos State
Ajibola, O. G.
10.1101/2024.11.02.24316307 — Posted: 2024-11-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).